Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Kingshan New Material is a specialized Chinese enterprise focused on the research, development, and production of high-performance adsorption and separation materials. The company primarily manufactures ion exchange resins and macroporous adsorption resins that are essential for downstream processing in the pharmaceutical and biotechnology industries. Their products are widely utilized for the purification of antibiotics, vitamins, amino acids, and natural plant extracts, as well as in water treatment and food processing. Headquartered in Lianyungang, Jiangsu, the company serves as a critical supplier for large-scale pharmaceutical manufacturing, enabling efficient separation and concentration of active ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Kingshan New Material.